Can a toxin gene NAAT be used to predict toxin EIA and the severity of Clostridium difficile infection?

[1]  Cynthia Y. Truong,et al.  Clostridium difficile PCR Cycle Threshold Predicts Free Toxin , 2017, Journal of Clinical Microbiology.

[2]  T. Peto,et al.  Comparison of Control of Clostridium difficile Infection in Six English Hospitals Using Whole-Genome Sequencing , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  T. Peto,et al.  Contribution to Clostridium Difficile Transmission of Symptomatic Patients With Toxigenic Strains Who Are Fecal Toxin Negative , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  O. Dekkers,et al.  European Society of Clinical Microbiology and Infectious Diseases: update of the diagnostic guidance document for Clostridium difficile infection. , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[5]  E. Bouza,et al.  Toxin B PCR cycle threshold as a predictor of poor outcome of Clostridium difficile infection: a derivation and validation cohort study. , 2016, The Journal of antimicrobial chemotherapy.

[6]  M. Wilcox,et al.  Clostridium difficile infection: epidemiology, diagnosis and understanding transmission , 2016, Nature Reviews Gastroenterology &Hepatology.

[7]  C. Polage,et al.  Toxin Immunoassays and Clostridium difficile Infection-Reply. , 2016, JAMA internal medicine.

[8]  M. Hellmich,et al.  PCR cycle threshold value predicts the course of Clostridium difficile infection. , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[9]  A. Galecki,et al.  Clostridium difficile ribotype 027: relationship to age, detectability of toxins A or B in stool with rapid testing, severe infection, and mortality. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  M. Delmée,et al.  Underdiagnosis of Clostridium difficile across Europe: the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID). , 2014, The Lancet. Infectious diseases.

[11]  Carmen Cadarso-Suárez,et al.  OptimalCutpoints: An R Package for Selecting Optimal Cutpoints in Diagnostic Tests , 2014 .

[12]  Matthias Bethge,et al.  Natter: A Python Natural Image Statistics Toolbox , 2014 .

[13]  A. Walker,et al.  Diverse sources of C. difficile infection. , 2014, The New England journal of medicine.

[14]  D. Crook,et al.  Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection , 2013, Lancet. Infectious Diseases (Print).

[15]  F. Raymond,et al.  Correlation between Clostridium difficile Bacterial Load, Commercial Real-Time PCR Cycle Thresholds, and Results of Diagnostic Tests Based on Enzyme Immunoassay and Cell Culture Cytotoxicity Assay , 2013, Journal of Clinical Microbiology.

[16]  R. Humphries,et al.  Performance of Clostridium difficile Toxin Enzyme Immunoassay and Nucleic Acid Amplification Tests Stratified by Patient Disease Severity , 2012, Journal of Clinical Microbiology.

[17]  G. French,et al.  Diagnostic testing for Clostridium difficile: a comprehensive survey of laboratories in England. , 2011, The Journal of hospital infection.

[18]  M. Wilcox.  Laboratory diagnosis of Clostridium difficile infection: in a state of transition or confusion or both? , 2011, The Journal of hospital infection.

[19]  M. Wilcox,et al.  Reference assays for Clostridium difficile infection: one or two gold standards? , 2010, Journal of Clinical Pathology.

[20]  P. Gilligan,et al.  Point-Counterpoint: What Is the Current Role of Algorithmic Approaches for Diagnosis ofClostridium difficile Infection? , 2010, Journal of Clinical Microbiology.

[21]  D. Gerding,et al.  Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA) , 2010, Infection Control & Hospital Epidemiology.

[22]  E. Marlowe,et al.  Clostridium difficile Testing in the Clinical Laboratory by Use of Multiple Testing Algorithms , 2010, Journal of Clinical Microbiology.

[23]  David J. Hand,et al.  Measuring classifier performance: a coherent alternative to the area under the ROC curve , 2009, Machine Learning.

[24]  A. Charlett,et al.  Comparison of Nine Commercially Available Clostridium difficile Toxin Detection Assays, a Real-Time PCR Assay for C. difficile tcdB, and a Glutamate Dehydrogenase Detection Assay to Cytotoxin Testing and Cytotoxigenic Culture Methods , 2009, Journal of Clinical Microbiology.

[25]  N. Shetty,et al.  Laboratory diagnosis of Clostridium difficile infection. An evaluation of tests for faecal toxin, glutamate dehydrogenase, lactoferrin and toxigenic culture in the diagnostic laboratory , 2009, British journal of biomedical science.

[26]  Richard Holliman,et al.  Diagnosis of Clostridium difficile infection by toxin detection kits: a systematic review. , 2008, The Lancet. Infectious diseases.

[27]  K. Carroll,et al.  Yield of Stool Culture with Isolate Toxin Testing versus a Two-Step Algorithm Including Stool Toxin Testing for Detection of Toxigenic Clostridium difficile , 2007, Journal of Clinical Microbiology.

[28]  D. Cardo,et al.  Estimating Health Care-Associated Infections and Deaths in U.S. Hospitals, 2002 , 2007, Public health reports.

[29]  K. Carroll,et al.  Effective Detection of Toxigenic Clostridium difficile by a Two-Step Algorithm Including Tests for Antigen and Cytotoxin , 2006, Journal of Clinical Microbiology.

[30]  S. Lewis,et al.  Stool form scale as a useful guide to intestinal transit time. , 1997, Scandinavian journal of gastroenterology.

[31]  D. Menees,et al.  Diverse Sources of C. difficile Infection , 2014 .